+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Shingles Vaccine Market - Global Forecast 2026-2032- Product Image
Shingles Vaccine Market - Global Forecast 2026-2032- Product Image
New

Shingles Vaccine Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 182 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5716361
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The shingles vaccine market is undergoing significant transformation, shaped by recent clinical innovations, evolving care delivery models, and an increased focus on adult immunization strategies. Senior leaders can leverage this momentum by aligning their organizational priorities with the dynamics driving improved vaccine access and operational performance.

Market Snapshot

The Shingles Vaccine Market grew from USD 2.02 billion in 2025 to USD 2.19 billion in 2026. It is expected to continue growing at a CAGR of 8.80%, reaching USD 3.66 billion by 2032. This trajectory is supported by technological advancements, expanding vaccination programs, and robust engagement from healthcare providers, payers, and public health agencies.

Scope & Segmentation

This report offers an in-depth view of the global shingles vaccine environment, emphasizing the following core dimensions:

  • Vaccine Types: Recombinant zoster vaccine and zoster vaccine live, each presenting unique clinical profiles, storage and handling requirements, and uptake patterns among providers.
  • Age Cohorts: Segments include 50–59 years, 60–69 years, and 70 years and above, reflecting variation in immune response and healthcare utilization.
  • Care Settings: Differentiation between clinics (community and private clinics) and hospitals (general and specialty hospitals), which impacts procurement, cold-chain needs, and patient flow.
  • Distribution Channels: Hospital pharmacies, online pharmacies (digital pharmacies and e-commerce platforms), and retail pharmacies (chain and independent), each with specific fulfillment logistics.
  • Dosage Patterns: Analysis includes both multi-dose and single-dose regimens, informing adherence initiatives and scheduling models.
  • Regions: Detailed coverage spans the Americas, Europe, Middle East & Africa, and Asia-Pacific, focusing on differences in infrastructure and policy that shape vaccine delivery outcomes.

Key Takeaways

  • Clinical progress has led to the prioritization of recombinant adjuvanted vaccines for older adults, supporting improved durability and immune response.
  • Innovation in digital health tools is enhancing patient identification and adherence monitoring, enabling more precise targeting of at-risk age groups and better inventory management.
  • Providers and payers face new operational challenges related to multi-dose regimens, requiring adjustments in care pathways and patient follow-up processes.
  • Regional variation in reimbursement models and cold-chain logistics demands locally tailored strategies, especially in areas with disparate access to care.
  • Collaboration between manufacturers, contract partners, logistics providers, and pharmacy networks remains critical for seamless vaccine distribution and equitable access.
  • Robust evidence generation and real-world data are essential for sustaining confidence among clinicians and securing alignment with payer priorities.

Tariff Impact on Market Dynamics

Tariff adjustments in key regions influence raw material sourcing, component import costs, and supply chain design for shingles vaccine producers. Strategic responses often include regionalizing manufacturing, diversifying suppliers, and renegotiating procurement contracts to manage cost volatility and support timely access. Tariffs can also reshape geographic priorities and incentivize investment in local production capabilities, which public health authorities may address through targeted subsidies or expedited regulatory pathways.

Methodology & Data Sources

The report integrates primary research, including interviews with clinicians, immunization leaders, payers, and supply chain executives, with secondary analysis of peer-reviewed studies, regulatory guidance, and safety surveillance reports. Data triangulation validates findings, while subject-matter expert review ensures clinical and commercial relevance.

Why This Report Matters

  • Delivers actionable insight into emerging vaccine technologies and operational trends directly impacting senior decision-making.
  • Enables tailored program design based on granular segmentation of age, dose, and distribution channel for more effective market targeting.
  • Offers a clear understanding of regional and policy variations needed to inform supply chain and manufacturing resilience strategies.

Conclusion

Strategic alignment of clinical innovation, operational agility, and stakeholder collaboration will determine continued progress in expanding shingles vaccine access. Monitoring ongoing developments and adapting implementation models will be essential for sustained success in this evolving marketplace.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Shingles Vaccine Market, by Vaccine Type
8.1. Recombinant Zoster Vaccine
8.2. Zoster Vaccine Live
9. Shingles Vaccine Market, by Dosage
9.1. Multi Dose
9.2. Single Dose
10. Shingles Vaccine Market, by Age Group
10.1. 50 To 59 Years
10.2. 60 To 69 Years
10.3. 70 Years And Above
11. Shingles Vaccine Market, by Distribution Channel
11.1. Hospital Pharmacies
11.2. Online Pharmacies
11.2.1. Digital Pharmacies
11.2.2. E-commerce Platforms
11.3. Retail Pharmacies
11.3.1. Chain Pharmacies
11.3.2. Independent Pharmacies
12. Shingles Vaccine Market, by End User
12.1. Clinics
12.1.1. Community Clinics
12.1.2. Private Clinics
12.2. Hospitals
12.2.1. General Hospitals
12.2.2. Specialty Hospitals
13. Shingles Vaccine Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Shingles Vaccine Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Shingles Vaccine Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Shingles Vaccine Market
17. China Shingles Vaccine Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AIM Vaccine Co., Ltd.
18.6. Bavarian Nordic A/S
18.7. Beijing Institute of Biological Products Co., Ltd.
18.8. Bharat Biotech International Limited
18.9. Biological E. Limited
18.10. CanSino Biologics Inc.
18.11. CanSinoBIO
18.12. Changchun BCHT Biotechnology Co., Ltd.
18.13. Chengdu Institute of Biological Products Co., Ltd.
18.14. Daiichi Sankyo Company, Limited
18.15. Dynavax Technologies Corporation
18.16. GeneOne Life Science
18.17. GlaxoSmithKline plc
18.18. Green Cross Corporation
18.19. Jiangsu Recbio Technology Co., Ltd.
18.20. Johnson & Johnson
18.21. Merck & Co., Inc.
18.22. Moderna, Inc.
18.23. Serum Institute of India Pvt. Ltd.
18.24. Sinovac Life Sciences Co., Ltd.
18.25. SK chemicals
18.26. Vaccitech plc
18.27. Valneva SE
18.28. Vaxart, Inc.
18.29. Yuxi Walvax Biotechnology Co., Ltd.
List of Figures
FIGURE 1. GLOBAL SHINGLES VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL SHINGLES VACCINE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL SHINGLES VACCINE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SHINGLES VACCINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL SHINGLES VACCINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SHINGLES VACCINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES SHINGLES VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA SHINGLES VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL SHINGLES VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL SHINGLES VACCINE MARKET SIZE, BY RECOMBINANT ZOSTER VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL SHINGLES VACCINE MARKET SIZE, BY RECOMBINANT ZOSTER VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL SHINGLES VACCINE MARKET SIZE, BY RECOMBINANT ZOSTER VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL SHINGLES VACCINE MARKET SIZE, BY ZOSTER VACCINE LIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL SHINGLES VACCINE MARKET SIZE, BY ZOSTER VACCINE LIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL SHINGLES VACCINE MARKET SIZE, BY ZOSTER VACCINE LIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL SHINGLES VACCINE MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL SHINGLES VACCINE MARKET SIZE, BY MULTI DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL SHINGLES VACCINE MARKET SIZE, BY MULTI DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL SHINGLES VACCINE MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL SHINGLES VACCINE MARKET SIZE, BY SINGLE DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SHINGLES VACCINE MARKET SIZE, BY SINGLE DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL SHINGLES VACCINE MARKET SIZE, BY 50 TO 59 YEARS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL SHINGLES VACCINE MARKET SIZE, BY 50 TO 59 YEARS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL SHINGLES VACCINE MARKET SIZE, BY 50 TO 59 YEARS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL SHINGLES VACCINE MARKET SIZE, BY 60 TO 69 YEARS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL SHINGLES VACCINE MARKET SIZE, BY 60 TO 69 YEARS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL SHINGLES VACCINE MARKET SIZE, BY 60 TO 69 YEARS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SHINGLES VACCINE MARKET SIZE, BY 70 YEARS AND ABOVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL SHINGLES VACCINE MARKET SIZE, BY 70 YEARS AND ABOVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL SHINGLES VACCINE MARKET SIZE, BY 70 YEARS AND ABOVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL SHINGLES VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL SHINGLES VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL SHINGLES VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DIGITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DIGITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL SHINGLES VACCINE MARKET SIZE, BY DIGITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL SHINGLES VACCINE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SHINGLES VACCINE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL SHINGLES VACCINE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL SHINGLES VACCINE MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL SHINGLES VACCINE MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL SHINGLES VACCINE MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL SHINGLES VACCINE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL SHINGLES VACCINE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL SHINGLES VACCINE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL SHINGLES VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL SHINGLES VACCINE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL SHINGLES VACCINE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL SHINGLES VACCINE MARKET SIZE, BY COMMUNITY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL SHINGLES VACCINE MARKET SIZE, BY COMMUNITY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL SHINGLES VACCINE MARKET SIZE, BY COMMUNITY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL SHINGLES VACCINE MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL SHINGLES VACCINE MARKET SIZE, BY PRIVATE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL SHINGLES VACCINE MARKET SIZE, BY PRIVATE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL SHINGLES VACCINE MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL SHINGLES VACCINE MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL SHINGLES VACCINE MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL SHINGLES VACCINE MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL SHINGLES VACCINE MARKET SIZE, BY SPECIALTY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL SHINGLES VACCINE MARKET SIZE, BY SPECIALTY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL SHINGLES VACCINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS SHINGLES VACCINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 112. EUROPE SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. EUROPE SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 114. EUROPE SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 115. EUROPE SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 116. EUROPE SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 117. EUROPE SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 118. EUROPE SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 119. EUROPE SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. EUROPE SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 121. EUROPE SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 124. MIDDLE EAST SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 127. MIDDLE EAST SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 132. AFRICA SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. AFRICA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 134. AFRICA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 135. AFRICA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 136. AFRICA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. AFRICA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 138. AFRICA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 139. AFRICA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. AFRICA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 141. AFRICA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL SHINGLES VACCINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. ASEAN SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. ASEAN SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 155. ASEAN SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 156. ASEAN SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 157. ASEAN SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 158. ASEAN SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 159. ASEAN SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 160. ASEAN SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. ASEAN SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 162. ASEAN SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 163. GCC SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. GCC SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 165. GCC SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 166. GCC SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 167. GCC SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 168. GCC SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 169. GCC SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 170. GCC SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. GCC SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 172. GCC SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 183. BRICS SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. BRICS SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 185. BRICS SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 186. BRICS SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 187. BRICS SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 188. BRICS SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 189. BRICS SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 190. BRICS SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. BRICS SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 192. BRICS SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 193. G7 SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. G7 SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 195. G7 SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 196. G7 SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 197. G7 SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 198. G7 SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 199. G7 SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 200. G7 SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. G7 SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 202. G7 SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 203. NATO SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. NATO SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 205. NATO SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 206. NATO SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 207. NATO SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 208. NATO SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 209. NATO SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 210. NATO SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. NATO SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 212. NATO SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. UNITED STATES SHINGLES VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 215. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 216. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 217. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 218. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 219. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 224. CHINA SHINGLES VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 225. CHINA SHINGLES VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 226. CHINA SHINGLES VACCINE MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 227. CHINA SHINGLES VACCINE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 228. CHINA SHINGLES VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 229. CHINA SHINGLES VACCINE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 230. CHINA SHINGLES VACCINE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 231. CHINA SHINGLES VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 232. CHINA SHINGLES VACCINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 233. CHINA SHINGLES VACCINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Shingles Vaccine market report include:
  • AIM Vaccine Co., Ltd.
  • Bavarian Nordic A/S
  • Beijing Institute of Biological Products Co., Ltd.
  • Bharat Biotech International Limited
  • Biological E. Limited
  • CanSino Biologics Inc.
  • CanSinoBIO
  • Changchun BCHT Biotechnology Co., Ltd.
  • Chengdu Institute of Biological Products Co., Ltd.
  • Daiichi Sankyo Company, Limited
  • Dynavax Technologies Corporation
  • GeneOne Life Science
  • GlaxoSmithKline plc
  • Green Cross Corporation
  • Jiangsu Recbio Technology Co., Ltd.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Moderna, Inc.
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Life Sciences Co., Ltd.
  • SK chemicals
  • Vaccitech plc
  • Valneva SE
  • Vaxart, Inc.
  • Yuxi Walvax Biotechnology Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages182
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.19 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.66 Billion
Compound Annual Growth Rate8.8%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Shingles Vaccine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Shingles Vaccine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 260 Pages
  • Global
From
Shingles Vaccines - Global Strategic Business Report - Product Image

Shingles Vaccines - Global Strategic Business Report

  • Report
  • 269 Pages
  • Global
From
Shingles Vaccine Market Report 2025 - Product Image

Shingles Vaccine Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Shingles Vaccine Market Size, Share & Trends Analysis Report By Product (Shingrix, Zostavax, SkyZoster), By Vaccine Type (Recombinant Vaccine, Live Attenuated Vaccine), By End Use (Private Healthcare Settings), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Shingles Vaccine Market Size, Share & Trends Analysis Report By Product (Shingrix, Zostavax, SkyZoster), By Vaccine Type (Recombinant Vaccine, Live Attenuated Vaccine), By End Use (Private Healthcare Settings), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
2025 Global Forecast for Shingles Vaccine Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Shingles Vaccine Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From

About the Shingles Vaccine Market

The Shingles Vaccine is a vaccine used to prevent shingles, a painful skin condition caused by the varicella-zoster virus. It is recommended for adults over the age of 50, and is available in both single-dose and two-dose formulations. The vaccine is typically administered by a healthcare provider, and is available in both private and public healthcare settings. The Shingles Vaccine market is a subset of the larger Vaccines market, which is estimated to be worth billions of dollars. The Shingles Vaccine market is expected to grow in the coming years, driven by an aging population and increased awareness of the condition. Some of the major companies in the Shingles Vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and AstraZeneca. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.